Type II Hyperlipidemia
2 clinical trials · Condition
◉ Watch Type II Hyperlipidemia
| Record | Firm | Date |
|---|---|---|
| A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels (NCT01388816) | Dr. Reddy's Laboratories Limited | 2011-07-01 |
| Efficacy and Safety Study of JTT-705 in Combination With Pravastatin 40 mg in Patients With Type II Hyperlipidemia (NCT00688896) | Akros Pharma Inc. | 2002-06-01 |
Track Type II Hyperlipidemia automatically
Every clearance here is in the API, with alerts when new ones post.